A novel series of 3,5-diiodo-4-(2-methyl-1H-imidazol-5-yl)benzoic acid analogs of amino acids, dipeptides and tripeptides was synthesized by using Pseudomonas aeruginosa and Klebsiella pneumoniae was also observed for synthesized imidazolopeptides.
Introduction
In past decades, imidazoles have proved their potential in development of pharmaceutically important organic compounds both of natural and synthetic origin E-mail: rajivdahiya04@yahoo.co.in (R. Dahiya). [1] . Imidazole analogs deal with a variety of bioactivities viz. antitumor [2, 3] , anti-HIV [4] , antimicrobial [5] [6] [7] [8] , anticonvulsant [9] , antitubercular [10] , antiprotozoal [11] , anti-inflammatory [12] , FTase and MAP kinase p38 inhibitory activities [13, 14] .
Literature is enriched with lot of work on synthesis of potent substituted imidazole derivatives with diverse pharmacological activities [15, 16] but only few reports have been received on peptide coupling of imidazoles. Thus keeping in view the biological potency of imidazole derivatives as well as taking advantage of biodegradability and biocompatibility of amino acids/peptides and further, in continuation of our research work on synthesizing peptide derivatives of heterocyclic and other aromatic compounds [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] , a novel series of 3,5-diiodo-4-(2-methyl-1H-5-imidazolyl)benzoyl amino acids and peptides with an anticipation to get potent agents of more therapeutic efficacy with lesser adverse effects.
Chemistry
4-Amino-3,5-diiodobenzoic acid (1) was prepared according to literature procedure [30] in good yields by iodination of p-aminobenzoic acid (PABA) using iodine monochloride. 3,5-Diiodo-4-(2-methyl-1H-5-imidazolyl)benzoic acid (2) was synthesized by diazotization of compound 1 followed by subsequent interaction with 2-methylimidazole in presence of aqueous cupric chloride. Dipeptides Boc-his-tyrOMe, Boc-phe-try-OMe and Boc-gly-gly-OMe were prepared from the corresponding Boc-amino acids viz. Boc-his-OH, Boc-phe-OH and Boc-gly-OH, and amino acid methyl ester hydrochlorides such as tyr-OMe.HCl, try-OMe.HCl and glyOMe.HCl using DCC and N-methylmorpholine (NMM) in chloroform [31] . Similarly, tripeptides Boc-pro-val-pro-OMe, Boc-ile-phe-leu-OMe and tetrapeptide Boc-glyhis-ala-try-OMe were prepared by coupling Boc-dipeptides with corresponding amino acid methyl ester hydrochlorides and dipeptide methyl esters. All Bocdi/tri/tetrapeptide methyl esters were deprotected at amino terminals using trifluoroacetic acid (TFA) prior to coupling.
3,5-Diiodo-4-(2-methyl-1H-5-imidazolyl)benzoic acid (2) was coupled with various L-amino acid methyl ester hydrochlorides/peptide methyl esters using Synthesis, Spectral and Antimicrobial Studies … 219 DCC/DIPC and TEA to get newly synthesized 3,5-diiodo-4-(2-methyl-1H-5-imidazolyl)benzoyl amino acid methyl esters (2a-b), dipeptide methyl esters (2c-e) and tri/tetrapeptide methyl esters (2f-h). Finally, compounds 2b-c and 2g-h were hydrolyzed with lithium hydroxide (LiOH) to get the corresponding acid derivatives 3a-d. Structures of all the newly synthesized compounds were confirmed by IR, 1 H NMR, 13 C NMR and mass spectral data. Elemental analysis of the novel compounds was performed for carbon, hydrogen and nitrogen content. The synthesis of compounds 2a-3d is mentioned in Scheme 1 and their physicochemical data is described in Table 1 .
Results and Discussion
All imidazolopeptide derivatives 2a-h were synthesized in good yields using Sch. 1. X = pro (2a), leu (2b), his-tyr (2c), phe-try (2d), gly-gly (2e), pro-val-pro (2f), ile-phe-leu (2g), gly-his-ala-try (2h), leu (3a), his-tyr (3b), ile-phe-leu (3c), gly-hisala-try (3d). 11 (25) 13 (25) 17 (6) 13(12.5) 15 (6) 13 (6) 14(12.5) 13(6) 2c 10(12.5) 9(50) 14 (6) 11(12.5) 21 (6) 19 (6) (25) 13 (6) 12(12.5) 22 (6) 18 (6) 15(12.5) 21(6) 3a
15 (25) 16 (25) 19 (6) 16(12.5) 17 (6) 15 (6) (25) 18 (6) 15(12.5) 25 (6) 21 (6) 2h, 3b and 3d displayed better activity against P. aeruginosa and compounds 2d-f exhibited better activity against C. albicans when compared to their corresponding dimethylbenzimidazolopeptides [18] . However, activity of compounds 2a-3d against gram positive bacteria was found to be less in comparison to earlier synthesized analogs. Moreover, presence of iodine atoms in nucleus was found to confer more antimicrobial activity especially against P. aeruginosa, K. pneumoniae, C. albicans and dermatophytes, as evident from previously synthesized noniodinated benzimidazolopeptide analogs [26] .
Experimental
Melting points were determined by open capillary method and are uncorrected.
L-amino acids, DIPC, DCC, TFA, NMM and TEA were procured from SpectroChem Ltd, Mumbai, India. IR spectra were recorded on Shimadzu 8700 fourier transform infrared spectrophotometer using a thin film supported on KBr pellets for solids and CHCl 3 as solvent for semisolids. 
Preparation of peptides
Amino acid methyl ester hydrochloride/dipeptide methyl ester (0.01 mol) was dissolved in CHCl 3 (15 ml). To this, NMM (0.021 mol) was added at 0 °C and the reaction mixture was stirred for 10 min. Boc-amino acid/dipeptide (0.01 mol) in CHCl 3 (15 ml) and DCC (0.01 mol) were added with stirring. After 36 h, the reaction mixture was filtered and the residue was washed with CHCl 3 (30 ml) and added to the filtrate. The filtrate was washed with 25 ml each of 5% NaHCO 3 and saturated NaCl solutions. The organic layer was dried over anhydrous Na 2 SO 4 , filtered and evaporated in vacuum. The crude product was crystallized from a mixture of Synthesis, Spectral and Antimicrobial Studies … 225 chloroform and n-hexane followed by cooling at 0 °C. Resulting Bocdi/tri/tetrapeptide methyl ester (0.01 mol) was dissolved in CHCl 3 (15 ml) and treated with trifluoroacetic acid (TFA, 0.02 mol). The mixture was stirred at RT for 1 h and washed with 25 ml of saturated NaHCO 3 solution. The resulting organic layer was dried over anhydrous Na 2 SO 4 and concentrated under reduced pressure.
Finally, crude product was purified by recrystallization with CHCl 3 and petroleum ether (b.p. 40-60 °C) to get the deprotected di/tri/tetrapeptide methyl esters.
Preparation of 3,5-diiodo-4-(2-methyl-1H-imidazol-5-yl)benzoic acid (2)
A mixture of 4-amino-3,5-diiodobenzoic acid (1) (38.9 g, 0.1 mol), dil.
hydrochloric acid (15%, 60 ml) and water (90 ml) was heated to get a clear solution.
After cooling, the solution was diazotized by addition of sodium nitrite solution (30%, 24 ml). To the filtrate of diazotized salt solution, 2-methylimidazole (8. 
Methyl 1-[3,5-diiodo-4-(2-methyl-1H-imidazol-5-yl)benzoyl]-L-leucinate (2b)
IR ( 
Methyl 1-[3,5-diiodo-4-(2-methyl-1H-imidazol-5-yl)benzoyl]-L-histidyl-Ltyrosinate (2c)
Methyl 1-[3,5-diiodo-4-(2-methyl-1H-imidazol-5-yl)benzoyl]-L-phenylalanyl-Ltryptophanate (2d)
3,5-Diiodo-4-(2-methyl-1H-imidazol-5-yl)benzoyl-L-leucine (3a)
